<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33066046</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>20</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Radon Exposure and Neurodegenerative Disease.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7439</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17207439</ELocationID><Abstract><AbstractText><i>Background:</i> To carry out a systematic review of scientific literature about the association between radon exposure and neurodegenerative diseases. <i>Methods:</i> We performed a bibliographic search in the following databases: Pub med (Medline), Cochrane, BioMed Central and Web of Science. We collected the data by following a predetermined search strategy in which several terms werecombined. After an initial search, 77 articles were obtained.10 of which fulfilled the inclusion criteria. Five of these 10 studies were related to multiple sclerosis (MS), 2 were about motor neuron diseases (MND), in particular amyotrophic lateral sclerosis (ALS) and 3 were related to both Alzheimer's disease (AD) and Parkinson's disease (PD). <i>Results:</i> The majority of the included articles, suggested a possible association between radon exposure and a subsequent development of neurodegenerative diseases. Some of the studies that obtained statistically significant resultsrevealed a possible association between radon exposure and an increase in MS prevalence. Furthermore, it was also suggested that radon exposure increases MND and AD mortality. Regarding AD and PD, it was observed that certainde cay products of radon-222 (<sup>222</sup>Rn), specifically polonium-210 (<sup>210</sup>Po) and bismuth-210 (<sup>210</sup>Bi), present a characteristic distributionpattern within the brain anatomy. However, the study with the highest scientific evidence included in this review, which investigated a possible association between the concentration of residential radon gas and the MS incidence, revealed no significant results. <i>Conclusions:</i> It cannot be concluded, although it is observed, that there is a possible causal association between radon exposure and neurodegenerative diseases. Most of the available studies are ecological so, studies of higher statistical evidence are needed to establish a causal relationship. Further research is needed on this topic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>G&#xf3;mez-Anca</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, University of Santiago de Compostela, 15782 Santiago, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros-Dios</LastName><ForeName>Juan Miguel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health, University of Santiago de Compostela, 15782 Santiago, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine, Santiago de Compostela University Teaching Hospital Complex, Santiago de Compostela, 15706 Santiago, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Biomedical Research on the Network of Epidemiology and Public Health (Centro DE Investigacion Biom&#xe9;dica en Red DE Epidemiolog&#xed;a Y Salud P&#xfa;blica), 15706 Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>Q74S4N8N1G</RegistryNumber><NameOfSubstance UI="D011886">Radon</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011886" MajorTopicYN="N">Radon</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer</Keyword><Keyword MajorTopicYN="N">Parkinson</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">radon</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>17</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33066046</ArticleId><ArticleId IdType="pmc">PMC7600778</ArticleId><ArticleId IdType="doi">10.3390/ijerph17207439</ArticleId><ArticleId IdType="pii">ijerph17207439</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. Ageing as a risk factor forneurodegenerativedisease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavarajappa B.S., Shivakumar M., Joshi V., Subbanna S. Endocannabinoidsystem in neurodegenerative disorders. J. Neurochem. 2017;142:624&#x2013;648. doi: 10.1111/jnc.14098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14098</ArticleId><ArticleId IdType="pmc">PMC5669051</ArticleId><ArticleId IdType="pubmed">28608560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kister I., Chamot E., Salter A.R., Cutter G.R., Bacon T.E., Herbert J. Disability in multiple sclerosis: A reference for patients and clinicians. Neurology. 2013;80:1018&#x2013;1024. doi: 10.1212/WNL.0b013e3182872855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872855</ArticleId><ArticleId IdType="pmc">PMC3653203</ArticleId><ArticleId IdType="pubmed">23427319</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xfc;ck W., Stadelmann C. The spectrum of multiple sclerosis: New lessons from pathology. Curr. Opin. Neurol. 2005;18:221&#x2013;224. doi: 10.1097/01.wco.0000169736.60922.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000169736.60922.20</ArticleId><ArticleId IdType="pubmed">15891403</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg N., Smith T.W. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 2015;5:e00362. doi: 10.1002/brb3.362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.362</ArticleId><ArticleId IdType="pmc">PMC4589809</ArticleId><ArticleId IdType="pubmed">26445701</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann. Neurol. 2007;61:288&#x2013;299. doi: 10.1002/ana.21117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21117</ArticleId><ArticleId IdType="pubmed">17444504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann. Neurol. 2007;61:504&#x2013;513. doi: 10.1002/ana.21141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21141</ArticleId><ArticleId IdType="pubmed">17492755</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson S., Blizzard L., Otahal P., Van Der Mei I., Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2011;82:1132&#x2013;1141. doi: 10.1136/jnnp.2011.240432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2011.240432</ArticleId><ArticleId IdType="pubmed">21478203</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J.L., Cole G. Alzheimer disease. JAMA. 2002;287:2335&#x2013;2338. doi: 10.1001/jama.287.18.2335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.287.18.2335</ArticleId><ArticleId IdType="pubmed">11988038</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley W.W., Miller B.L. Enfermedad de Alzheimer. In: Jameson J.L., Kasper D.L., Longo D.L., Fauci A.S., Hauser S.L., Loscalzo J., editors. Harrison Principios de Medicina Interna. 20th ed. Volume 2. McGraw-HillEducation; Madrid, Spain: 2018. pp. 3108&#x2013;3114.</Citation></Reference><Reference><Citation>Angot E., Brundin P. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 2009;15(Suppl. 3):S143&#x2013;S147. doi: 10.1016/S1353-8020(09)70802-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1353-8020(09)70802-8</ArticleId><ArticleId IdType="pubmed">20082977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaglia M., Mammi S., Bubacco L. Structural insights on physiological functions and pathological effects of &#xb1; alpha-synuclein. FASEB J. 2008;23:329&#x2013;340. doi: 10.1096/fj.08-119784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-119784</ArticleId><ArticleId IdType="pubmed">18948383</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lau L.M.L., Breteler M.M.B. Epidemiology of Parkinson&#x2019;s disease. Lancet Neurol. 2006;5:525&#x2013;535. doi: 10.1016/S1474-4422(06)70471-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70471-9</ArticleId><ArticleId IdType="pubmed">16713924</ArticleId></ArticleIdList></Reference><Reference><Citation>Pringsheim T., Jette N., Frolkis A., Steeves T.D. The prevalence of Parkinson&#x2019;s disease: A systematic review and meta-analysis. Mov. Disord. 2014;29:1583&#x2013;1590. doi: 10.1002/mds.25945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25945</ArticleId><ArticleId IdType="pubmed">24976103</ArticleId></ArticleIdList></Reference><Reference><Citation>Olanow C.W., Klein C., Schapira A.H.V. Enfermedad de Parkinson. In: Jameson J.L., Kasper D.L., Longo D.L., Fauci A.S., Hauser S.L., Loscalzo J., editors. Harrison Principios de MedicinaInterna. 20th ed. Volume 2. McGraw-HillEducation; Madrid, Spain: 2018. pp. 3120&#x2013;3132.</Citation></Reference><Reference><Citation>Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., Ross G.W., Strickland D., Eeden S.K.V.D., Gorell J. Pooled Analysis of Tobacco Use and Risk of Parkinson Disease. Arch. Neurol. 2007;64:990&#x2013;997. doi: 10.1001/archneur.64.7.990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.7.990</ArticleId><ArticleId IdType="pubmed">17620489</ArticleId></ArticleIdList></Reference><Reference><Citation>Breckenridge C.B., Berry C., Chang E.T., Sielken R.L., Jr., Mandel J.S. Association between Parkinson&#x2019;s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS ONE. 2016;11:e0151841. doi: 10.1371/journal.pone.0151841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151841</ArticleId><ArticleId IdType="pmc">PMC4824443</ArticleId><ArticleId IdType="pubmed">27055126</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Handbook on Indoor Radon: A Public Health Perspective. WHO; Geneva, Switzerland: 2009.</Citation></Reference><Reference><Citation>Nussbaum E. Research and Development Reports UR503. University of Rochester; Rochester, NY, USA: 1957. Radon solubility in body tissues and in fatty acids.</Citation></Reference><Reference><Citation>National Research Council . Biological Effects of Ionizing Radiation (BEIR) VI Report: The Health Effects of Exposure to Radon. National Academy Press; Washington, DC, USA: 1999.</Citation></Reference><Reference><Citation>Committee on the Biological Effects of Ionizing Radiations . Health Risks of Radon and Other Internally Deposited Alpha-Emitters: BEIR IV. National Academy Press; Washington, DC, USA: 1988.</Citation></Reference><Reference><Citation>Hopke P.K. The indoor radon problem explained for the layman. In: Hopke P.K., editor. Radon and Its Decay Products. American Chemical Society; Washington, DC, USA: 1987. pp. 572&#x2013;586.</Citation></Reference><Reference><Citation>Barros-Dios J.M., Ruano-Ravina A., Gastelu-Iturri J., Figueiras A. Factors underlying residential radon concentration: Results from Galicia, Spain. Environ. Res. 2007;103:185&#x2013;190. doi: 10.1016/j.envres.2006.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2006.04.008</ArticleId><ArticleId IdType="pubmed">16729995</ArticleId></ArticleIdList></Reference><Reference><Citation>Darby S.C., Radford E.P., Whitley E. Radon exposure and cancers other than lung cancer in Swedish iron miners. Environ. Health Perspect. 1995;103(Suppl. 2):45&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1518838</ArticleId><ArticleId IdType="pubmed">7614946</ArticleId></ArticleIdList></Reference><Reference><Citation>Salgado-Espinosa T., Barros-Dios J.M., Ruano-Ravina A. Radon exposure and oropharyngeal cancer risk. Cancer Lett. 2015;369:45&#x2013;49. doi: 10.1016/j.canlet.2015.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2015.08.025</ArticleId><ArticleId IdType="pubmed">26335172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruano-Ravina A., Aragon&#xe9;s N., Kelsey K.T., P&#xe9;rez-R&#xed;os M., Pi&#xf1;eiro M., L&#xf3;pez-Abente G., Barros-Dios J.M. Residential radon exposure and brain cancer: An ecological study in a radon prone area (Galicia, Spain) Sci. Rep. 2017;7:3595. doi: 10.1038/s41598-017-03938-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-03938-9</ArticleId><ArticleId IdType="pmc">PMC5472649</ArticleId><ArticleId IdType="pubmed">28620182</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xe4;uner E.V., Andersen Z.J., Andersen C.E., Pedersen C., Gravesen P., Ulbak K., Hertel O., Loft S., Raaschou-Nielsen O. Residential Radon and Brain Tumour Incidence in a Danish Cohort. PLoS ONE. 2013;8:e74435. doi: 10.1371/journal.pone.0074435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074435</ArticleId><ArticleId IdType="pmc">PMC3774631</ArticleId><ArticleId IdType="pubmed">24066143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruano-Ravina A., Dacosta-Urbieta A., Barros-Dios J.M., Kelsey K.T. Radon exposure and tumors of the central nervous system. Gac. Sanit. 2017;32:567&#x2013;575. doi: 10.1016/j.gaceta.2017.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gaceta.2017.01.002</ArticleId><ArticleId IdType="pubmed">28318756</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa-Lorenzo R., Barros-Dios J.M., Aldrey M.R., Caram&#xe9;s S.C., Ruano-Ravina A. Residential radon and cancers other than lung cancer: A cohort study in Galicia, a Spanish radon-prone area. Eur. J. Epidemiol. 2016;31:437&#x2013;441. doi: 10.1007/s10654-016-0134-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-016-0134-x</ArticleId><ArticleId IdType="pubmed">26972807</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves-Kirkby C.J., Denman A.R., Campbell J., Crockett R.G., Phillips P.S., Rogers S. Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales. J. Environ. Radioact. 2016;154:1&#x2013;14. doi: 10.1016/j.jenvrad.2015.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jenvrad.2015.12.003</ArticleId><ArticleId IdType="pubmed">26809141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nussbaum E., Harsh J.B. Radon Solubility in Fatty Acids and Triglycerides. J. Phys. Chem. 1958;62:81&#x2013;84. doi: 10.1021/j150559a021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/j150559a021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykken G.K., Mom&#x10d;ilovi&#x107; B. Environmental radon, high energy alpha particle radiation and multiple sclerosis connection revisited; Proceedings of the 48th Annual Meeting of the Health Physics Society; San Diego, CA, USA. 20&#x2013;24 July 2003.</Citation></Reference><Reference><Citation>Cooper R. Multiple sclerosis: An immune legacy? Med. Hypotheses. 1997;49:307&#x2013;311. doi: 10.1016/S0306-9877(97)90196-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-9877(97)90196-1</ArticleId><ArticleId IdType="pubmed">9352500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lykken G.I., Ong H.S., Penland J.G. Radon in humans: More dynamic than we thought. Health Phys. 1990;58:S31.</Citation></Reference><Reference><Citation>Momcilovi&#x107; B., Lykken G.I., Cooley M. Natural distribution of environmental radon daughters in the different brain areas of an Alzheimer Disease victim. Mol. Neurodegener. 2006;1:11. doi: 10.1186/1750-1326-1-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-1-11</ArticleId><ArticleId IdType="pmc">PMC1579210</ArticleId><ArticleId IdType="pubmed">16965619</ArticleId></ArticleIdList></Reference><Reference><Citation>Momcilovi&#x107; B., Alkhatib H.A., Duerre J.A., Cooley M.A., Long W.M., Harris R.T., Lykken G.I. Environmental radon daughters reveal pathognomonic changes in the brain proteins and lipids in patients with Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease, and cigarette smokers. Arh. Hig. Toksikol. 1999;50:347&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851740</ArticleId></ArticleIdList></Reference><Reference><Citation>Mom&#x10d;ilovi&#x107; B., Alkhatib H.A., Duerre J.A., Cooley M., Long W.M., Harris T.R., Lykken G.I. Environmental lead-210 and bismuth-210 accrue selectively in the brain proteins in Alzheimer Disease and brain lipids in Parkinson&#x2019;s Disease. Alzheimer Dis. Assoc. Disord. 2001;15:106&#x2013;115. doi: 10.1097/00002093-200104000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-200104000-00012</ArticleId><ArticleId IdType="pubmed">11403330</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberd&#xf6;rster G., Sharp Z., Atudorei V., Elder A., Gelein R., Kreyling W., Cox C. Translocation of Inhaled Ultrafine Particles to the Brain. Inhal. Toxicol. 2004;16:437&#x2013;445. doi: 10.1080/08958370490439597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08958370490439597</ArticleId><ArticleId IdType="pubmed">15204759</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey N.L., Wesson D.W., Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol. Dis. 2018;109:226&#x2013;248. doi: 10.1016/j.nbd.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5972535</ArticleId><ArticleId IdType="pubmed">28011307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N.K., Sharma R., Mathur D., Sharad S., Minhas G., Bhatia K., Anand A., Ghosh S.P. Role of ionizing radiation in neurodegenerative diseases. Front. Aging Neurosci. 2018;10:134. doi: 10.3389/fnagi.2018.00134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00134</ArticleId><ArticleId IdType="pmc">PMC5963202</ArticleId><ArticleId IdType="pubmed">29867445</ArticleId></ArticleIdList></Reference><Reference><Citation>Urr&#xfa;tia G., Bonfill X. Declaraci&#xf3;nPRISMA: Unapropuesta para mejorar la publicaci&#xf3;n de revisionessistem&#xe1;ticas y metaan&#xe1;lisis. Med. Cl&#xed;nica. 2010;135:507&#x2013;511. doi: 10.1016/j.medcli.2010.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2010.01.015</ArticleId><ArticleId IdType="pubmed">20206945</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuberger J., Lynch S., Nazir N., Keighley J. Residential case-control study of radon and multiple sclerosis. Mult. Scler. 2009;15:1402.</Citation></Reference><Reference><Citation>Bartlett D.T., Gilvin P.J., Still R., Dixon D.W., Miles J.C.H. The NRPB radon personal dosimetry service. J. Radiol. Prot. 1988;8:19&#x2013;24. doi: 10.1088/0952-4746/8/1/001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0952-4746/8/1/001</ArticleId></ArticleIdList></Reference><Reference><Citation>Strand T., Green B.M.R., Lom&#xe5;s P.R., Magnus K., Stranden E. Radon Inorskeboliger. National Institute of Radiation Hygiene; Akershus, Norway: 1991. (In Norwegian with an English Abstract)</Citation></Reference><Reference><Citation>Lykken G.I., Magness A.T., Momcilovic B. Whole body Bi-214 and bedroom radon concentration in Multiple Sclerosis. FASEB J. 2008;22:708&#x2013;709.</Citation></Reference><Reference><Citation>Gilmore M., Grennan E. A pilot study of the relationship between multiple sclerosis and the physical environment in northwest Ireland. Environ. Geochem. Health. 2003;25:157&#x2013;163. doi: 10.1023/A:1021229805676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1021229805676</ArticleId><ArticleId IdType="pubmed">12901091</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf8;lviken B., Celius E., Nilsen R., Strand T. Radon: A Possible Risk Factor in Multiple Sclerosis. Neuroepidemiology. 2003;22:87&#x2013;94. doi: 10.1159/000067102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000067102</ArticleId><ArticleId IdType="pubmed">12566959</ArticleId></ArticleIdList></Reference><Reference><Citation>Neilson S., Robinson I., Rose F.C. The correlation of motor neuron disease with radiation: An objection to the hypothesis of Neilson et al. J. Neurol. 1997;244:57&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">9007747</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz G.G., Klug M.G. Motor neuron disease mortality rates in U.S. states are associated with well water use. Amyotroph. Lateral Scler. Front. Degener. 2016;17:528&#x2013;534. doi: 10.1080/21678421.2016.1195409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1195409</ArticleId><ArticleId IdType="pmc">PMC5152538</ArticleId><ArticleId IdType="pubmed">27324739</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos N.V., Vieira C.L., Saldiva P.H.N., Mazzilli B.P., Saiki M., Saueia C.H., De Andr&#xe9; C.D.S., Justo L.T., Nisti M.B., Koutrakis P. Levels of Polonium-210 in brain and pulmonary tissues: Preliminary study in autopsies conducted in the city of Sao Paulo, Brazil. Sci. Rep. 2020;10:180. doi: 10.1038/s41598-019-56973-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56973-z</ArticleId><ArticleId IdType="pmc">PMC6957520</ArticleId><ArticleId IdType="pubmed">31932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro J., Briggs N.M. Assessment of Variations in Radiation Exposure in the United States. U.S. Environmental Protection Agency Office of Radiation and Indoor Air; Washington, DC, USA: 2005. pp. 1&#x2013;35.</Citation></Reference><Reference><Citation>Douglas P.S., Carr J.J., Cerqueira M.D., Cummings J.E., Gerber T.C., Mukherjee D., Taylor A.J. Developing an Action Plan for Patient Radiation Safety in Adult Cardiovascular Medicine.  [(accessed on 13 October 2020)]; Available online:  https://www.ahajournals.org/doi/full/10.1161/HCI.0b013e318252e9d9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HCI.0b013e318252e9d9</ArticleId></ArticleIdList></Reference><Reference><Citation>Westlund K. Distribution and mortality time trend of multiple sclerosis and some other diseases in norway. Acta Neurol. Scand. 1970;46:455&#x2013;483. doi: 10.1111/j.1600-0404.1970.tb05806.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1970.tb05806.x</ArticleId><ArticleId IdType="pubmed">5504330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer S., Rheinstein P.H., Rosenzweig K.E. Association of Radon Background and Total BackgroundIonizingRadiationwithAlzheimer&#x2019;s Disease Deaths in U.S. States. J. Alzheimers. Dis. 2017;59:737&#x2013;741. doi: 10.3233/JAD-170308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170308</ArticleId><ArticleId IdType="pubmed">28671130</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan R., Robison S., Munzer J., Bradley W.G. Deficient DNA repair in amyotrophic lateral sclerosis cells. J. Neurol. Sci. 1987;79:189&#x2013;203. doi: 10.1016/0022-510X(87)90272-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(87)90272-3</ArticleId><ArticleId IdType="pubmed">3112312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson R., Bell M.V. Molecular species composition of glicerol phospholipids from white matter human brain. Lipids. 1993;28:13&#x2013;17. doi: 10.1007/BF02536353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02536353</ArticleId><ArticleId IdType="pubmed">8446006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrer S., Rheinstein P.H. A derangement of the brain wound healing process may cause some cases of Alzheimer&#x2019;s disease. Discov. Med. 2016;22:43&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5158009</ArticleId><ArticleId IdType="pubmed">27585229</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlivet J., H&#xe9;mon D., Cl&#xe9;ro &#xc9;., Ielsch G., Laurier D., Guissou S., Lacour B., Clavel J., Goujon S. Ecologicalassociationbetweenresidential natural backgroundradiationexposure and theincidencerate of childhood central nervoussystemtumors in France, 2000&#x2013;2012. J. Environ. Radioact. 2020;211:106071. doi: 10.1016/j.jenvrad.2019.106071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jenvrad.2019.106071</ArticleId><ArticleId IdType="pubmed">31600676</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins M.C.H., Fatigati F.L., V&#xe9;spoli T.C., Martins L.C., Pereira L.A., Saldiva P.H.N., Braga A.L.F. Influence of socioeconomic conditions on air pollution adverse health effects in elderly people: An analysis of six regions in Sao Paulo, Brazil. J. Epidemiol. Community Health. 2004;58:41&#x2013;46. doi: 10.1136/jech.58.1.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.58.1.41</ArticleId><ArticleId IdType="pmc">PMC1757032</ArticleId><ArticleId IdType="pubmed">14684725</ArticleId></ArticleIdList></Reference><Reference><Citation>Forastiere F., Stafoggia M., Tasco C., Picciotto S., Agabiti N., Cesaroni G., Perucci C.A. Socioeconomic status, particulate air pollution, and daily mortality: Differential exposure or differential susceptibility. Am. J. Ind. Med. 2007;50:208&#x2013;216. doi: 10.1002/ajim.20368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajim.20368</ArticleId><ArticleId IdType="pubmed">16847936</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans G.W., Kantrowitz E. Socioeconomic status and health: The potential role of environmental risk exposure. Annu. Rev. Public Health. 2002;23:303&#x2013;331. doi: 10.1146/annurev.publhealth.23.112001.112349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.publhealth.23.112001.112349</ArticleId><ArticleId IdType="pubmed">11910065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zag&#xe0; V., Lygidakis C., Chaouachi K., Gattavecchia E. Polonium and Lung Cancer. J. Oncol. 2011;2011:1&#x2013;11. doi: 10.1155/2011/860103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/860103</ArticleId><ArticleId IdType="pmc">PMC3136189</ArticleId><ArticleId IdType="pubmed">21772848</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>